BioCryst Reports Inducement Grants Under Nasdaq Rule

BioCryst Pharmaceuticals announced inducement grants issued under Nasdaq Listing Rule 5635(c)(4). These grants are typically awarded to new employees or non-employee directors as an incentive. The announcement follows standard procedure for companies adhering to exchange regulations regarding equity compensation. While specific details of the grants are not provided, the disclosure confirms BioCryst's compliance with Nasdaq's requirements for such incentive awards.